5 Q’s for Charles Fisher, CEO of Unlearn.AI

The Center for Data Innovation spoke with Charles Fisher, chief executive officer and founder of Unlearn.AI, a U.S. firm that uses AI to build digital replicas of patients in clinical trials. Fisher discussed how this approach can address patient recruitment, one of the main challenges associated with trials for diseases like Alzheimer’s.


Enter your email address to download paper.

Click the link to begin download.
Oops! Something went wrong while submitting the form.
Press

Unlearn.AI named to the 2021 CB Insights AI 100 List of Most Innovative Artificial Intelligence Startups

Blog

Welcoming Dr. Taylor to Unlearn.AI’s Board of Directors

Press

Unlearn Appoints AstraZeneca’s Chief Medical Officer Ann E. Taylor, M.D. to Board of Directors

Ann E. Taylor, M.D., Chief Medical Officer at AstraZeneca, has joined the Unlearn Board of Directors.
I’m honored to have such an inspirational and experienced leader like Dr. Taylor join our board.
The AI 100 is CB Insights' annual list of the 100 most promising private AI companies in the world.